- BuildingDesign News - Construction / Services News Archives

Article Date: 5th April 2018

Selectaglaze - Clean, Private & Secure Environments for Laboratories Enhanced with Secondary Glazing

Secondary Glazing - Psioxus Therapeutics - Primary Glazing - Obscurity Glass

Selectaglaze - PsiOxus Therapeutics Lab

PsiOxus Therapeutics Ltd. (PsiOxus) is a UK and US based cancer therapeutics company recently listed 25th in the Sunday Times Hiscox Tech Track 100 in 2017 for its ‘Gene Therapy for Cancer’ platform technology for the treatment of solid tumours. PsiOxus has now expanded into 21,000 sq ft of new facilities including a state-of-the-art research and development laboratory in The Quadrant at the Abingdon Science Park. The Quadrant was purchased in January 2016 by Addington Capital and Europa Capital. In total, the 75,000 sq ft scheme is renovating the R&D and office accommodation, internally and upgrading laboratory equipment, heating/cooling systems, lighting, and windows.

The main contractor, Morgan Lovell specified Selectaglaze, the leading supplier of secondary glazing to come up with a solution to enhance the thermal insulation and security of the building in specific areas.

The works included the introduction of secondary glazing at the new PsiOxus facility to meet the specification of an oncolytic virus research and development laboratory by enhancing the thermal and security aspects of the primary glazing.

Selectaglaze - PsiOxus Therapeutics LabThe original primary windows were thermally inefficient, draughty and let heat escape. PsiOxus’ research and development environment demands the utmost sanitation so a glazing solution had to meet these requirements. As part of the refurbishment, windows with fire ratings splitting the labs and corridors were also necessary to conform to building regulations.

Selectaglaze met the brief by installing a total of 15 horizontal slider units with 6mm toughened low- E glass in the 2 and 3 pane options to all of the external primary windows. The inverted u-channel section was included to sit in the bottom of each frame to minimise the dust traps and enhance the ease of cleaning. This is ideal for tissue culture labs where there is a requirement for infection control. All of the secondary glazing on the ground floor was fitted with Satinovo obscurity glass to provide increased lab privacy.

22 Series 40 fixed light units were also installed as viewing panels in the research and development laboratories. The Series 40 has a sturdier frame which can house higher weights of glass than required in a standard unit. The vision panels within the internal walls were fitted in 6mm toughened glass and in the lab areas, units were fitted with a 10mm Pyrodur glass providing 30 minutes of fire integrity. PsiOxus put in fume cupboards, new upstands and trunking after the secondary glazing was fitted. This was to ensure that the units could be fitted with ease as any new equipment or upstands may have restricted the unit fitting into the reveal.

Selectaglaze - PsiOxus Therapeutics LabThermally speaking, the U-values have been improved, now exceeding 1.9 and draughts have been eradicated. The flush frames and Satinovo glass now ensure that any experiments will be contained within the laboratories thus promoting an optimised cleanable and controlled environment. An additional benefit not originally specified was the improvement to acoustic insulation. Selectaglaze units combined with a cavity of at least 100mm from the primary window, offer a significant noise reduction from the outside environment.

The PsiOxus staff are already reaping the benefits of the working atmosphere in the labs thanks to the successful on-time installation of secondary glazing.

With fifty years’ experience in the industry and Royal Warrant holders since 2004, Selectaglaze is the UK’s leading secondary glazing specialist. The company offers a full technical advisory service, bespoke production and installation.

BuildingDesign Media © - BuildingDesign Portal | BuildingDesign Tenders